Zika phase II clinical trial
Ended Awarded Last action
- Contract number
- HHSN27200013
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,598,514
Award facts
- Contract value 85% obligated
-
- $22,598,514.17 Current, with exercised options
- $26,698,456.17 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Westlake, MD 20817, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$888,028 | |
| Change Order | $0 | |
| Change Order | $8,300,000 | |
| Exercise an Option | $7,098,149 | |
| Funding Only Action | $3,836,159 | |
| Original award | $4,252,234 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The $26,698,456.17 cost-plus-fixed-fee contract is a delivery order with a completion date of July 31, 2022. It is not a set-aside contract.
The Emmes Company LLC is an experienced provider of comprehensive research support services to federal agencies, particularly the National Institutes of Health (NIH). This contract award is part of the $545 million Comprehensive and Rapid Response for NIAID Research Programs contract vehicle, under which Emmes provides clinical trials support, data management, and regulatory compliance assistance for NIAID's research initiatives. The company has also secured numerous other prime contracts and grants from various NIH institutes to support their complex biomedical research programs.
Quick answers
Who was awarded contract HHSN27200013?
HHSN27200013 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2016.
How much is contract HHSN27200013 worth?
The government has obligated $22,598,514 on HHSN27200013. Its potential value, with all options, is $26,698,456.
Is contract HHSN27200013 an order under another contract?
Yes. HHSN27200013 is a delivery order under HHSN272201000049I, an indefinite delivery contract.
Was contract HHSN27200013 competed?
The extent of competition for HHSN27200013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award